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Dressing is an intervention aimed to prevent infection in central venous catheter. This 
study aimed to analyze the frequency of catheter-related infection and skin toxicity in 
the use of transparent film in Hickman’s catheter in patients who underwent allogeneic 
hematopoietic stem cell transplantation. A case series with 10 cases was carried out. Due 
to the presence of exudate on the average for 12 days, sterile gauze dressing was used for 
12.9 days (average). Transparent film was used, on average, for 15.1 days. Catheters were 
precociously removed due to infection in four cases. The highest degree of skin toxicity 
occurred in a case that used gauze dressing and in three cases with film. The transparent film 
permitted visualization of the exit site of the catheter and changes with longer intervals.
Descriptors: Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation; 
Catheterization, Central Venous; Bandages; Occlusive Dressings.
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O uso do filme transparente de poliuretano no cateter venoso central 
de longa permanência
O curativo é intervenção que visa a prevenção de infecção no cateter venoso central. 
O estudo teve como objetivo analisar a frequência de infecção, relacionada ao cateter, 
e toxicidade cutânea, na utilização do curativo de poliuretano no cateter de Hickman, 
implantado em pacientes submetidos ao transplante de células-tronco hematopoéticas 
alogênico. Para tal, realizou-se uma série de casos, constituída por 10 casos. O exsudato 
esteve presente em média por 12 dias, sendo necessário o uso do curativo de gaze 
estéril, com fita adesiva, por 12,9 dias (média). O curativo de poliuretano foi utilizado, 
em média, por 15,1 dias. A retirada precoce do cateter por infecção ocorreu em quatro 
casos. O maior grau de toxicidade cutânea aconteceu em um caso que utilizou o curativo 
de gaze e em três casos com filme. O filme transparente permitiu a visualização do sítio 
de saída do cateter e a troca com intervalos maiores.
Descritores: Transplante de Células-Tronco Hematopoéticas; Transplante de Medula 
Óssea; Cateterismo Venoso Central; Bandagens; Curativos Oclusivos.
Uso de la película transparente de poliuretano en el catéter venoso 
central de larga permanencia
El curativo es una intervención que tiene por objetivo la prevención de infección en el 
catéter venoso central. El estudio tuvo como objetivo analizar la frecuencia de infección 
relacionada al catéter y la toxicidad cutánea en la utilización del curativo de poliuretano 
en el catéter de Hickman implantado en pacientes sometidos al trasplante de células 
tronco hematopoyéticas alogénicas. Para esto se realizó una serie de 10 casos. El 
exudado estuvo presente en promedio por 12 días, siendo necesario el uso del curativo 
de gasa estéril con cinta adhesiva por 12,9 días (promedio). El curativo de poliuretano fue 
utilizado en promedio por 15,1 días. La retirada precoz del catéter debido a surgimiento 
de infección ocurrió en cuatro casos. El mayor grado de toxicidad cutánea ocurrió en un 
caso que se utilizó el curativo de gasa y en tres casos que utilizaron la película. La película 
transparente permitió la visualización del sitio de salida del catéter y la realización del 
cambio en intervalos mayores.
Descriptores: Trasplante de Células Madre Hematopoyéticas; Trasplante de Médula Ósea; 
Cateterismo Venoso Central; Vendajes; Apósitos Oclusivos.
Introduction
The surgical implantation of an indwelling 
central venous catheter (CVC) is needed to perform 
hematopoietic stem cell transplantation (HSCT), and 
Hickman’s catheter is indicated for most patients. That is 
the first preparatory action for HSCT, but the catheter’s 
presence can cause complication, including infection 
caused by the rupture of the patient’s skin integrity, 
which can lead to death(1-3).
Placing a dressing on the CVC exit site aims to reduce 
catheter-related infection. A wide range of materials is 
used as CVC dressing. Literature reports on the use 
of the following materials: sterile gauze with adhesive 
tape, transparent polyurethane film, highly transpiration 
moisture permeable transparent polyurethane film and 
hydrocolloid dressing(4-6).
Among advantages appointed for the use of 
transparent polyurethane film in indwelling catheter 
dressings for HSCT patients, longer dwelling time stands 
out, decreasing skin irritation manifested through local 
injuries, which cause discomfort and pain during dressing 
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change. Besides this aspect, there is evidence of greater 
satisfaction and better comfort from the patient’s 
perspective, material cost reduction and decreased 
needs for the nursing team(7-9).
Despite these advantages, literature presents 
disagreement on the efficacy of transparent film. 
Some studies(6,10-11) evidenced no difference in infection 
incidence levels when comparing this type of dressing 
with the use of sterile gauze. Other studies(4,12-13), on the 
other hand, appointed increased incidence of CVC-related 
infection when polyurethane dressings are used.
In Brazilian literature, two randomized and 
controlled clinical trials assessed the use of polyurethane 
dressing, but in peripheral venous catheters. In both 
studies, pediatric patients were divided in three groups: 
transparent film, sterile gauze and adhesive tape and 
hypo-allergenic adhesive tape alone(14-15).
One study aimed to analyze the influence of the 
dressing type on the dwelling time of peripheral venous 
catheters. Its results appointed that the group that 
used sterile gauze dressings and adhesive tape showed 
a longer dwelling time for the device(14). The other study 
identified the reasons for removal and adverse events 
related to the use of peripheral intravenous catheters 
in children according to the dressing types. The results 
demonstrated a statistically significant difference in the 
group with sterile gauze and adhesive tape regarding 
the decrease of adverse events like phlebitis, infiltration, 
folding of the device and accidental removal(15).
It should also be highlighted that studies described in 
international literature(4-13) were conducted with funding 
from the pharmaceutical industry and in countries with 
a moderate climate. Thus, this study aims to assess the 
use of polyurethane dressing in Hickman’s catheter in 
hospitalized patients in a tropical country with a warm 
and humid climate. This unedited research arouses 
concerns regarding the climate’s possible influence on 
the dressing type’s performance. This concern was also 
identified in Brazilian studies(14-15).
In view of the divergences detected in literature 
and the lack of Brazilian research, this study was 
conducted to develop research resulting in significant 
contributions to clinical nursing practice.
Aim
To analyze the frequency of catheter-related 
infection and skin toxicity in the use of polyurethane 
dressing on the exit site of Hickman’s catheter implanted 
in allogeneic HSCT patients.
Material and method
This is a case series, which is a methodological 
option to test products or procedures. In this design, 
the sample is not randomly allocated and no control 
group is constituted, which makes it difficult to isolate 
the effect of the research intervention. The evidenced 
results can be confronted with literature, however, and 
provide evidence on the use and safety of the product 
or procedure under assessment(16).
The study was carried out at an allogeneic HSCT 
hospitalization unit in a general public hospital in the 
interior of São Paulo State. Regarding inclusion criteria, 
the sample comprised subjects in the age range of 
16 years or older; who were candidates for related 
allogeneic HSCT, involving the infusion of hematopoietic 
stem cells from bone marrow and peripheral blood, and 
surgically implanted Hickman’s catheter under aseptic 
conditions at the surgical center.
Subjects were excluded who expressed a previous 
adverse reaction to the polyurethane dressing; with 
active skin injuries; with bacteremia or fungemia within 
14 days before the start of data collection, as this is the 
expected period to solve these complications after the 
start of adequate treatment, and/or had a short-term 
central venous catheter implanted.
The six nurses who worked at the unit, together with 
one of the researchers, observed the research subjects 
daily and assessed the study variables. Therefore, they 
were trained, using the teaching program strategy.
Initially, a pre-test was performed with multiple 
choice questions on the following items: CVC dressing 
procedure technique, characteristics of different 
coverage types, way to apply and remove the transparent 
film, signs and symptoms of CVC-related infection and 
skin toxicity. After applying the pre-test among the 
nurses, the responsible researcher gave a presentation 
on the contents of the pre-test and demonstrated how 
to use the transparent film. At the end of the class, the 
nurses were asked to answer the questionnaire again, 
which was called post-test. Nurses who scored at least 
80% on the post-test were considered apt to start data 
collection. It should be highlighted that the mean score 
on the pre-test was 86.6%, against 92.5% on the post-
test, showed that all nurses reached the cut-off score 
already on the pre-test.
For data collection, an instrument was elaborated 
with information regarding subjects’ characteristics; 
the conditioning regimen, that is, the chemotherapeutic 
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agents used for bone marrow aplasia and whether 
associated with radiotherapy or not; date of 
transplantation; number of dressings applied; type of 
coverage used; and signs and symptoms of infection 
according to Centers for Disease Control and Prevention 
(CDC)(17) guidelines and of skin toxicity.
The instrument was submitted to face and content 
validation by four experts (nurses, two with professional 
experience in care to HSCT patients and two active 
in teaching, research and community service at a 
public state university). The experts suggested some 
modifications in the way the items were presented, 
which the researchers accepted.
The independent variable was the OpSite 
polyurethane dressing, with changes programmed 
every seven days. Dependent variables were: skin 
toxicity and CVC-related infection. Skin toxicity was 
assessed as degree 1 – presence of macula, papule 
or erythema, asymptomatic; degree 2 – presence 
of macula, papule or erythema, with itch or other 
local associated symptoms; degree 3 – presence of 
macula, papule or bladder surpassing the borders of 
the dressing and degree 4 – presence of exfoliative 
or ulcerative dermatitis(8). The CVC-related infection 
was divided in exit site infection; tunnel infection and 
catheter-related bloodstream infection, which needs to 
be confirmed by a blood culture results, according to 
the CDC classification(17).
Data were collected between August 2007 and 
July 2008. The nurses and the responsible researcher 
applied the dressing as follows: after the implantation 
of Hickman’s catheter, all patients used the sterile 
gauze dressing fixed with adhesive tape until the 
exudate ceased; skin antisepsis was performed in three 
clockwise movements with sterile gauze drenched 
in 0.5% alcohol-chlorhexidine. In case of exudate, 
sterile gauze was used, fixed with thin adhesive type 
and changed daily. When no exudate was present, 
transparent polyurethane film was used (OpSite® IV 
3000), with changes programmed every 7 days. The 
presence of exudate after the implant is due to the 
surgical wound healing process, which starts with the 
inflammatory or exudative phase, taking between four 
and six days. The accumulation of exudate below the 
dressing is a source of concern, due to the risk of local 
proliferation of microorganisms(18).
The trained nurses assessed signs and symptoms 
of skin toxicity daily at the dressing adhesion site and, 
in case of differences from the previous day, the data 
were confirmed through the responsible researcher’s 
observation. The trained nurses observed signs and 
symptoms of CVC-related infection daily. Every day, the 
responsible researcher consulted laboratory results of 
complete blood counts, blood cultures and skin cultures 
in the patients’ files and data the nurses recorded on 
the data collection instrument during daily clinical 
assessment for the classification of the catheter-related 
infection type.
Data were analyzed descriptively, using statistical 
measures like arithmetic means, standard deviation, 
median, minimum and maximum.
Approval for this research was obtained from 
the Research Ethics Committee at the University of 
São Paulo at Ribeirão Preto Medical School Hospital 
das Clínicas on February 28th 2007 (protocol No 
14222/2006). All study participants signed the Free 
and Informed Consent Term after the researcher had 
provided information on the research goals, highlighting 
that they could cease participating at any time, without 
any kind of risk or harm.
Results
The sample comprised 10 subjects, six (60%) 
women and four (40%) men. The average age was 
41.9 years, ranging from 16 to 57 years. With regard to 
the baseline disease, four patients had leukemia, three 
myelodysplastic syndrome, two severe aplastic anemia 
and one Blackfan Diamond syndrome. Three deaths 
(30%) occurred during the hospitalization period. The 
median time passed between diagnosis and HSCT was 
eight months, ranging between two and 504 months. 
The conditioning regimen fludarabine and busulphan 




Rev. Latino-Am. Enfermagem 2010 Nov-Dec;18(6):1212-20.
Table 1 – Case distribution according to number of assessed days, days with exudate, number of days with sterile 
gauze and polyurethane dressings, time between surgical implant of central venous catheter and start of conditioning 
regimen, Ribeirão Preto, 2007-2008
Case Assessment (days) Exudate (days)
Gauze and adhesive 
tape (days) Polyurethane (days)
Surgical implant of central venous catheter 
and conditioning regimen (hours)**
1 22 10 16 06 20
2 37 18 18 19 12
3 34 25 24 10 36
4 39 15 16 23 192
5 36 10 11 25 48
6 20 05 07 13 18
7 12 09 09 03 72
8 25 17 17 08 24
9 28 03 03 25 48
10 27 08 08 19 48
Total 280 120 129 151 518
Mean 28 12 12.9 15.1 51.8
SD* 8.61 6.68 6.33 8.15 52.5
* Standard Deviation
** Time between surgical implant of central venous catheter and start of conditioning regimen
In Table 1, it is observed that the CVC was assessed 
for periods ranging from 12 to 39 days, with a mean 28 
days, totaling 280 observations. Exudate was present 
for an average 12 days, entailing the need to use sterile 
gauze dressings with adhesive tape for 12.9 days (mean). 
Polyurethane dressings were used for an average 15.1 
days. The time between the surgical implant of the CVC 
and the start of the conditioning regimen ranged from 
12 to 192 hours, with a mean 51.8 hours, that is, on 
the average, the conditioning regimen started two days 
after the implant.
Table 2 – Case distribution according to additional dressing change and cutaneous toxicity degree. Ribeirão Preto, 
2007-2008
Case
Frequency Cutaneous toxicity degree 








1 0 5 - degree 4
2 0 0 degree 4 -
3 0 1 degree 1 degree 2
4 0 1 - degree 1
5 0 1 - degree 4
6 0 2 - -
7 0 0 - -
8 1 0 - -
9 0 3 - degree 4
10 0 2 - -
Total 1 15 - -
Mean 0.10 1.50 - -
SD* 0.31 1.58 - -
*Standard Deviation
Additional change of the sterile gauze dressing with 
adhesive tape was necessary once; in the polyurethane 
dressing, on the other hand, additional changes occurred 
15 times (Table 2). The mean additional change of the 
sterile gauze dressing with adhesive tape was 0.1 times, 
against 1.5 times for the polyurethane dressing. In 
three cases, no additional change of the polyurethane 
dressing was needed. Hence, despite the need for 
additional change in seven cases, in comparison with 
the daily gauze dressing change, the dwelling time of 
the film dressing was longer.
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Skin toxicity was more frequent during the use 
of transparent polyurethane film, with three degree-4 
cases. On the opposite, only one case developed 
degree-4 skin toxicity during the use of sterile gauze 
dressing with adhesive tape.
Table 3 – Case distribution according to characteristics of central venous catheter exit site, surgery duration, 

















1 20 1 3 0 0 0 0 0
2 17 0 2 0 2 0 0 0
3 0 0 0 0 0 0 0 0
4 22 0 0 0 0 0 0 0
5 0 0 7 0 0 0 0 0
6 15 0 2 0 0 0 2 0
7 8 1 10 1 0 12 0 1
8 8 0 0 0 1 1 0 0
9 27 0 2 0 2 0 0 0
10 18 0 0 0 0 0 0 0
Total 135 2 26 1 5 13 2 1
Mean 13.5 0.2 2.6 0.1 0.5 1.3 0.2 0.1
SD** ±9.16 ±0.42 ±3.37 ±0.31 ±0.84 ±3.77 ±0.42 ±0.31
Case Surgery duration (minutes) Neutropenia (days) Reason CVC* withdrawal Dwelling removed CVC (days)
1 30 21 ISS 22
2 110 23 - -
3 30 30 - -
4 25 13 - -
5 25 15 - -
6 70 32 ICSRC 20
7 55 24 ITS 12
8 60 27 - -
9 30 20 - -
10 60 24 ISS 27
Total 495 227 - 81
Mean 49.5 22.7 - 20.2
SD** ±27.2 ±6.0 - ±6.2
* Central Venous Catheter
** Standard deviation
ISS – exit site infection; ICSRC – CVC-related bloodstream infection; ITS – subcutaneous tunnel infection
As shown in Table 3, the average presence of 
erythema ≤2 cm on the CVC exit site was 13.5 days, 
and was absent in two cases; four cases presented 
erythema ≤2 cm before the application of the 
transparent polyurethane film and five on the day or 
after the application of the polyurethane dressing. As for 
edema and pain, their occurrence is low and happened 
on the first two post-operative days, except for one case 
when they persisted since the immediate post-operative 
until the removal of the CVC due to subcutaneous tunnel 
infection. Heat was observed in two cases, both of which 
developed CVC-related infection.
It is also appointed in Table 3 that the mean 
neutropenia period was 22.7 days and that four cases 
developed catheter-related infection (exit site infection, 
subcutaneous tunnel infection and bloodstream 
infection). In these cases, the mean CVC dwelling time 
was 20.2 days.
Discussion
Allogeneic HSCT implies greater infection risk due 
to the rupture of skin integrity as a result of the CVC 
implant, presence of prolonged neutropenia due to high 
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chemotherapy doses, use of immunosuppressants in the 
prophylaxis of graft-against-host disease, besides the 
need for long catheter dwelling times(19-20).
In this study, on the average, the start of the 
conditioning regimen occurred two days after the 
catheter implant, although a study indicates that 
chemotherapeutic agents should not be administered 
until at least five to seven days after the surgery to 
avoid commitment of initial healing events(18). Thus, as 
patients did not present an adequate platelet function 
due to the baseline disease and were submitted to 
chemotherapy with fibroblast-inhibiting agents, wound 
exudate continued for prolonged periods, demonstrating 
that healing was compromised and decreasing the 
efficacy of tunneling, which is the formation of fibrosis 
around the catheter cuff, which permits controlling the 
ascent of microorganisms.
The prolonged presence of exudate indicates the 
need to use sterile gauze dressing with adhesive tape, 
as the accumulation of secretion below the polyurethane 
dressing causes frequent additional changes, due to the 
risk of local microorganism proliferation. In one case, it 
was observed that the presence of exudate demanded 
the daily change of the polyurethane dressing, generating 
ulcerated lesions across the adhesion surface.
Additional changes of the polyurethane dressing 
occurred in seven cases due to the presence of dirt or 
detachment of the coverage. Thus, the polyurethane 
dressing needed additional change, hampering the 
dwelling time proposed in this study (seven days). 
These data differ from results evidenced in literature, 
which recommends dwelling times of more than seven 
days for transparent polyurethane film(7-8).
The highest degree of skin toxicity (degree 4) was 
observed in three cases when polyurethane dressings 
were used, against only one case for sterile gauze 
dressings with adhesive tape. It should be highlighted 
that the lesions mainly affected the adhesion site of the 
dressing borders.
In literature, studies on skin toxicity related to the 
adhesion of polyurethane dressing in HSCT patients have 
shown controversial results. In a clinical trial, the results 
evidenced a statistically significant difference, with lower 
skin toxicity in the group with a two-day change interval 
in comparison with the group where dressings were 
changed every five days(7). On the other hand, a study 
that assessed 112 patients demonstrated a statistically 
significant difference in the reduction of skin toxicity for 
the group in which dressings were changed at longer 
intervals (study with the same research design as the 
abovementioned research). Among the 32 patients who 
presented skin toxicity degree ≥2, eight belonged to 
the group whose dressing was changed every 15 days 
and 24 to the group with dressing changes every four 
days(8).
In a study of healthy individuals with simulation of 
repeated applications and removals of adhesive tape for 
dressings or intravascular catheter fixation on integral 
skin, the results demonstrated epidermal alterations, 
leading to irritation and many points of rupture in the 
stratum corneum(21).
Besides this aspect, patients submitted to HSCT 
receive high doses of chemotherapeutic agents, which 
in most cases impede cell division for tissue repair. 
Busulphan is an agent associated with systemic 
dermatological toxicity, predisposing to alterations like 
dermatitis, erythema, dryness and cutaneous fragility, 
contributing to the appearance of skin toxicity on the 
dressing adhesion site(8). In the present study, that drug 
was used in seven cases and, in five of these, patients 
presented some degree of cutaneous toxicity.
Local heat is related to the presence of an 
inflammatory process and an objective piece of data, 
obtained by palpating the exit site and subcutaneous 
tunnel. Polyurethane dressings impede this observation, 
functioning as an isolating thermal barrier, without 
allowing the evaluator to feel local temperature 
differences.
Exit site erythema is a characteristic attributed to 
exit site infection according to the CVC-related infection 
criteria recommended in CDC guidelines(17) to prevent 
intravascular catheter infection. In this study, a fact that 
can appoint this local infection was the early removal of 
four catheters due to CVC-related infection.
The period after the CVC implant can represent 
risk due to the skin trauma caused by the procedure 
and the delayed healing of patients submitted to HSCT, 
demonstrating the importance of catheter exit site care 
for infection prevention and control, such as the dressing 
type(22-23). One preoccupying piece of information was the 
appearance of erythema ≤2 cm on the day or after the 
application of the polyurethane dressing in five cases.
In four cases under assessment, the CVC was removed 
early due to intravascular catheter related infection (D+4 
– four days after the infusion of hematopoietic stem cells, 
D+6 – six days after the infusion of hematopoietic stem 
cells, D+15 - 15 days after the infusion of hematopoietic 
stem cells and D+20 – 20 days after the infusion of 
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hematopoietic stem cells), with two exit site infection, one 
subcutaneous tunnel infection and one catheter-related 
bloodstream infection. The appearance of infection caused 
an average CVC dwelling time of 20.2 days, ranging from 
12 to 27 days.
On the opposite, in a retrospective study, it was 
identified that infection related to Hickman’s catheter 
occurred in 10 patients (9.1%) submitted to allogeneic 
HSCT and, on the average, 32 days after the implant 
(D+31 – 31 days after the infusion of hematopoietic 
stem cells). In the study, it is highlighted that Hickman 
catheter related infection was defined as the presence of 
erythema, edema, pain and/or purulent secretion on the 
exit site and/or in the subcutaneous tunnel associated 
with fever(22). Also, the research indicated that the 
time for the myeloid grafting (confirmed by absolute 
neutrophil counts of more than 500 cells/mm3 for three 
days in a row) was identified as the sole risk factor for 
Hickman’s catheter infection, with an average 18 days 
for the grafting.
In the present study, six cases were admitted with 
neutropenia (absolute granulocyte counting ≤1000 cells/
mm3, without any upward trend) before the start of the 
conditioning regimen. This prolonged the neutropenia 
period, which took an average 22.7 days. Three out of 
four cases that developed CVC-related infection were 
admitted with neutropenia.
In literature, recommendations to use polyurethane 
dressing is based on the following aspects: decreased 
manipulation of exit site, diminished cost and nursing 
time, besides promoting patients’ comfort without 
increasing the intravascular catheter-related infection 
risk(6,10-11). These research results diverge, however, 
hampering decision making in clinical practice.
In this sense, one study is observed that assessed 
three different type of short-term CVC dressings: sterile 
gauze with adhesive tape, transparent polyurethane 
film and highly transpiration moisture permeable 
transparent polyurethane film regarding the incidence 
of intravascular catheter-related bloodstream infection. 
The results appointed a statistically significant difference 
in the reduction of CVC related infection with the use 
of highly transpiration moisture permeable transparent 
polyurethane film changed every 72 hours(24).
On the opposite, in a randomized clinical trial 
conducted to compare common and highly transpiration 
moisture permeable transparent polyurethane film in 
short-term CVC, changed every 48 hours, the results 
evidenced similar quantities of fluid, microorganism 
growth in the skin culture and catheter-tip colonization 
among the dressing types(25).
Hence, the recommendation to use transparent 
polyurethane film is controversial, mainly due to studies 
that demonstrated increased incidence of infection with 
a seven-day change interval(12-13).
The identification of Gram-positive microorganisms 
as causal agents of Hickman catheter-related infection 
indicates that the local microbiota may be related in case 
of CVC contamination(22-23). This shows the importance of 
dressing care during the healing period and formation 
of fibrosis around the cuff with a view to catheter exit 
site infection prevention and control, as there seems 
to exist a relation with lumen and later bloodstream 
contamination.
Conclusions
The results evidenced in this case series 
permitted inferring some observations about the use of 
polyurethane dressing in patients submitted to HSCT: 
the surgical Hickman catheter implant followed by the 
start of the conditioning regimen may have prolonged 
the healing period and the presence of exudate. This 
made it unfeasible to use polyurethane dressings, on 
the average, during the first 12 days; the transparent 
polyurethane film permitted constant visualization of 
the exit site and dressing change at longer intervals, 
but its additional change may have contributed to the 
appearance of skin toxicity; the presence of this dressing 
made it difficult to identify local heat; the appearance of 
erythema ≤2 cm, a sign of exit site infection, may be 
related with the presence of the polyurethane dressing.
To assess the efficacy of health interventions, it is 
known that the “gold standard” is experimental research 
development, such as randomized controlled clinical 
trials. In view of the type of patient under analysis, 
however, the researchers believe that this kind of study 
would only be possible in a multicenter study or during 
an extensive data collection period. Hence, they consider 
that, despite the study design used (case series), the 
present study results offer evidence that can contribute 
to nursing decision making in clinical practice as to what 
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